Most red light pages jump straight to results: smoother skin, faster recovery, better sleep. This page goes one step back and asks a simpler question. When red or near-infrared light lands on a living cell, what do scientists think actually happens?
The short answer is that there's a leading theory with decent lab support, some open questions, and a lot less human evidence than you might expect. We read each source below on PubMed on 20 October 2026. Where a finding comes from cells in a dish or from animals, we say so.
One thing first. Our own devices don't have confirmed specifications yet, so nothing here is a claim about what a Redlume Ritual product does. It's background on the research, written so the other pages in this series make sense.
In the scientific literature, using low levels of red or near-infrared light on the body is usually called photobiomodulation, often shortened to PBM. Older papers call it low-level laser therapy or low-level light therapy. They mean broadly the same thing: light at levels too low to heat or cut tissue, used to see whether it changes how cells behave.
Researchers mostly work in two bands.
Red light, roughly 630 to 670 nm in the studies we read. You can see it as a deep red glow.
Near-infrared, roughly 810 to 850 nm in most of the same studies. You can't see it.
Plenty of studies use both at once. A 2015 cell study by Ferraresi and colleagues, for example, used a cluster of 630 nm and 850 nm LEDs. We go into the differences between the two in red light vs near infrared.
Light gets scattered and absorbed as it passes through skin, so less of it reaches each deeper layer. Ash and colleagues (2017) used computer modelling of layered skin to estimate this. They found that penetration depth increases as wavelength gets longer, and that a beam wider than about 10 mm added little extra depth at 1 to 3 mm below the surface.
The leading idea is that red and near-infrared light is absorbed by an enzyme in mitochondria called cytochrome c oxidase. Reviews by Hamblin and colleagues describe the hypothesis that light frees nitric oxide from this enzyme, so the cell's energy chain runs a little faster and makes more ATP. Most of the direct evidence comes from cells and animals, and some researchers think other molecules matter more.
Most studies we read used red light somewhere around 630 to 670 nm, near-infrared around 810 to 850 nm, or both. For example, a 2015 cell study by Ferraresi and colleagues used 630 nm and 850 nm LEDs together.
Not according to the lab research. Reviews by Huang and colleagues in 2009 and 2011 describe a biphasic dose response, where a low dose stimulated cells and a much higher dose had a weaker or opposite effect.
No, and we don't claim that. Our device specifications are not confirmed and have not been tested in any study. This page explains what researchers think happens when cells meet red light under lab and trial conditions.
Red light for muscle recovery, graded honestly: what trials on exercise performance and muscle soreness found, where results were mixed, and what we won't claim.
Red light and collagen, graded honestly: what cell studies, skin biopsies and face trials measured, how strong the evidence is, and what we won't claim.
Does red light boost cellular energy? What studies of mitochondria and ATP found, why most of the evidence is from cells and animals, and what we won't claim.
Red light and sleep, graded honestly: what small trials and one meta-analysis found, why red light at night differs from blue, and what we won't claim.
What early studies of near-infrared light to the head have looked at for mood, stress and thinking, how small they are, and why we make no claims.
That's a model, not a measurement in people, and depth alone doesn't tell you whether anything useful happens when the light gets there. But it's why near-infrared is often described as reaching further than red.
Inside most of your cells are mitochondria, often described as the cell's power stations. They make ATP, the molecule cells use as an energy currency.
The leading theory is that the main target for red and near-infrared light is an enzyme in the mitochondria called cytochrome c oxidase. It's the last step in the chain that mitochondria use to make ATP. Karu (2010), one of the early researchers in the field, set out the case for this enzyme as the light's main receiver in a review. De Freitas and Hamblin (2016) describe it as one of the most important light-absorbing molecules in this research, partly because it contains metal centres that absorb light into the near-infrared range.
Why would absorbing light make a difference? The most cited explanation involves nitric oxide.
The idea, described by de Freitas and Hamblin (2016) and again by Hamblin (2018), goes like this. In stressed cells, nitric oxide can bind to cytochrome c oxidase and slow it down. Light may knock that nitric oxide loose. With the brake off, the chain runs more freely, the charge across the mitochondrial membrane rises, and the cell makes more ATP.
The reviews also describe knock-on signals: brief changes in reactive oxygen species, calcium and other messengers that switch genes on or off. A second theory involves light-sensitive ion channels in the cell membrane that let calcium in.
Hamblin (2018) adds an important twist. Healthy cells and stressed cells can respond in apparently opposite ways to the same light. That matters, because a lot of lab work uses cells that have been deliberately stressed.
The mechanism isn't just a theory on paper. A few lab studies have measured it directly.
Back in 1984, Passarella and colleagues shone a helium-neon laser, which gives off red light, on mitochondria taken from rat livers. They reported a rise in the membrane charge and in ATP production. That's isolated mitochondria in a test tube, not a living person.
Ferraresi and colleagues (2015) used mouse muscle cells grown in a dish. After a single 90-second dose of combined red and near-infrared LED light, both mitochondrial membrane potential and ATP were higher than in untreated cells, with the biggest difference 3 to 6 hours later. Again, that's cells, not people.
In humans, the direct evidence is thin. Wang and colleagues (2017) shone a 1064 nm laser on the foreheads of 11 healthy volunteers and used a light-based scanner to track changes underneath. Compared with placebo, they saw more of the oxidised form of cytochrome c oxidase in the brain tissue they measured. It's an interesting signal, but it's 11 people, a laser at a longer wavelength than most home devices, and a measurement of a chemical change rather than any effect you'd notice.
It would be misleading to present this as settled. Sommer (2019) argued that cytochrome c oxidase is not the main target for near-infrared light at all, and that water bound to the mitochondria plays the bigger role. That's a minority position in the papers we read, but it's a reminder that the field's best explanation is still a hypothesis.
This is the part most product pages skip, and it's the part that matters most.
Irradiance is how much light power lands on each square centimetre, usually given in milliwatts per square centimetre (mW/cm²).
Time is how long that light stays on the same area, in seconds.
Multiply the two and you get the dose, also called fluence or energy density, in joules per square centimetre (J/cm²). In the Ferraresi cell study, 28 mW/cm² for 90 seconds gave about 2.5 J/cm².
Jenkins and Carroll (2011) set out what researchers should report so that anyone can repeat a study: wavelength, power, beam area, irradiance, time and the resulting dose, among others. When a paper or a product leaves those out, it's very hard to know what was actually delivered. Our guide to reading device specifications goes through what to look for.
You might expect that if a little light helps a cell, a lot would help more. The lab research says otherwise.
Huang and colleagues (2009) described a biphasic dose response, where low doses stimulated cells and higher doses had less effect or the opposite effect. Their 2011 update reported the same pattern in ATP and mitochondrial membrane potential in cell studies, and in mouse experiments where both the dose per session and the number of sessions were varied.
A clear example comes from skin cells. Mamalis and Jagdeo (2018) gave human skin fibroblasts, the cells that make collagen, very high doses of red LED light: 320 and 640 J/cm². At those levels, a key growth signal fell, and the authors noted their earlier work showing that such high doses reduced fibroblast growth and collagen production. Compare that with the 2.5 J/cm² in the Ferraresi study. The same colour of light, at a very different dose, pushed cells in a different direction.
That's why "more power" or "longer sessions" isn't a sensible goal on its own, and why device instructions matter.
Each of these pages looks at one area of research and grades how strong the evidence is.
Talk to your GP or pharmacist before using any red light device if you're pregnant, take medicine that makes your skin sensitive to light, have an eye condition, or have epilepsy that's triggered by flashing or flickering light. Read our pages on eye safety and side effects before you start.
Here's the honest summary. There's a reasonable, lab-backed theory for how red and near-infrared light could change what a cell does. It centres on mitochondria and cytochrome c oxidase. The effect depends heavily on dose, and too much can work against you. Most of the direct mechanism evidence comes from cells and animals, and some scientists dispute the main target.
What this doesn't do is prove that any home device produces a benefit you'd notice. That's a question for human trials, which are covered topic by topic in the pages above.
Why red light is a growing area of recovery research, what is still unknown about dose, devices and blinding, and which better-designed trials are under way.